Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial
posted by Research Admin 1 on 30 January 2019
Year of Publication
Lipids Health Dis. 2019, Jan 26; 18(1):31
Journal article (peer reviewed)
This clinical trial explored the effects of curcumin and/or omega-3 polyunsaturated fatty acid administration on at-risk participants and found that, "Lowering insulin resistance and dyslipidaemia may not only enhance glycaemic control but also preserve the β-cell function, reducing the overall risk of developing type 2 diabetes."
Type of Study
How to Access
To read the full abstract, and for information on how to access the full text, go to: https://www.ncbi.nlm.nih.gov/pubmed/30684965 or contact your DHB library, or organisational or local library for assistance.